Covid-19 vaccine effectiveness against general SARS-CoV-2 infection from the omicron variant: A retrospective cohort study

Lior Rennert, Zichen Ma, Christopher S. McMahan, Delphine Dean
doi: https://doi.org/10.1101/2022.05.06.22274771

Article Information

doi 
https://doi.org/10.1101/2022.05.06.22274771
History 
  • May 7, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Lior Rennert, PhD1,*,
  2. Zichen Ma, PhD1,
  3. Christopher S. McMahan, PhD2 and
  4. Delphine Dean, PhD3
  1. 1Department of Public Health Sciences, Clemson University, Clemson, SC, USA
  2. 2School of Mathematical and Statistical Sciences, Clemson University, Clemson, SC, USA
  3. 3Department of Bioengineering, Clemson University, Clemson, SC, USA
  1. ↵*Corresponding author
    Lior Rennert, PhD, Department of Public Health Sciences, Clemson University, 517 Edwards Hall, Clemson, SC, 29601, 864-656-7434, liorr{at}clemson.edu
Back to top
Posted May 07, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Covid-19 vaccine effectiveness against general SARS-CoV-2 infection from the omicron variant: A retrospective cohort study
Lior Rennert, Zichen Ma, Christopher S. McMahan, Delphine Dean
medRxiv 2022.05.06.22274771; doi: https://doi.org/10.1101/2022.05.06.22274771
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area